University College London Hospitals at ESMO 2026

Oct 23–27, 2026 Madrid, Spain ~37k attendees Website

University College London Hospitals takes part in 5 sessions at ESMO 2026 in Madrid. Its program centres on sarcoma, including predictive signatures in tumours with damaged DNA, and on lower gastrointestinal cancers. Other sessions work through real-world treatment decisions in chemotherapy-refractory metastatic colorectal cancer, including progression and side effects, and cover melanoma and other skin tumours.

OrganizationESMO 2026 Attendance
Cancer centre & hospital
NHS foundation trust running teaching hospitals in central London, United Kingdom, linked to University College London.
Chair
Fri Oct 23
16:15–17:45
Beyond traditional therapy: The impact of emerging approaches on sarcoma treatment
with Centre Léon Bérard
Sarcoma, CNS, head & neck and rare cancers
Talk
Fri Oct 23
17:15–17:35
Predictive signatures in sarcomas with "damaged" DNA: A matter of caution or excitement?
Beyond traditional therapy: The impact of emerging approaches on sarcoma treatment
Sarcoma, CNS, head & neck and rare cancers
Chair
Sat Oct 24
14:45–16:15
Rapid oral: Gastrointestinal tumours, lower digestive
with Università Cattolica del Sacro Cuore, Memorial Sloan Kettering Cancer Center
Gastrointestinal cancers
Abstract
Sat Oct 24
15:47–15:59
Invited Discussant LBA31 and LBA32
Rapid oral: Gastrointestinal tumours, lower digestive
Gastrointestinal cancers
Chair
Sun Oct 25
10:15–11:45
Rapid oral: Melanoma and other skin tumours
with Institut Strauss, University Medical Center Hamburg-Eppendorf
Melanoma & skin cancers
Abstract
Sun Oct 25
10:57–11:09
Invited Discussant LBA59, LBA60 and 2486RO
Rapid oral: Melanoma and other skin tumours
Melanoma & skin cancers
Chair
Mon Oct 26
08:30–10:00
Rapid oral: Sarcoma
with Memorial Sloan Kettering Cancer Center, Vall d'Hebron Institute of Oncology (VHIO)
Sarcoma, CNS, head & neck and rare cancers
Abstract
Mon Oct 26
08:45–08:57
Invited Discussant 3717RO, 3718RO and 3719RO
Rapid oral: Sarcoma
Sarcoma, CNS, head & neck and rare cancers
Satellite
Mon Oct 26
13:05–13:20
Evolving Landscape & Unmet Need in Chemorefractory mCRC
Takeda - mCRC Borderless Tumor Board: Navigating real-world treatment decisions in chemorefractory mCRC · with Hospital Universitario de Navarra, University Hospitals Birmingham
Gastrointestinal cancers
Satellite
Mon Oct 26
13:20–13:40
Clinical Scenario 1: Progression Following Prior Therapy
Takeda - mCRC Borderless Tumor Board: Navigating real-world treatment decisions in chemorefractory mCRC · with Hospital Universitario de Navarra, University Hospitals Birmingham
Gastrointestinal cancers
Satellite
Mon Oct 26
13:40–14:00
Clinical Scenario 2: Patient with Treatment Related Toxicities
Takeda - mCRC Borderless Tumor Board: Navigating real-world treatment decisions in chemorefractory mCRC · with Hospital Universitario de Navarra, University Hospitals Birmingham
Gastrointestinal cancers

Explore the full ESMO 2026 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in Madrid. Leave your work email and we’ll be in touch.

Privacy

Download the full ESMO 2026 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from University College London Hospitals

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the European Society for Medical Oncology. Submit a correction